血液形成の老化は,IL-1駆動の緊急骨髄形成を促進する

Matthew D Park^1,2,3, Jessica Le Berichel^1,2,3, Pauline Hamon^1,2,3

¹Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Science (New York, N.Y.)

|September 5, 2024

まとめ

免疫系が老化すると,インタールイキン-1α (IL-1) を生成する骨髄細胞が増えるので,がんの進行が加速する. この経路を標的にすることで腫瘍の成長を遅らせ新しいがん治療法が生まれます

科学分野:

免疫学
腫瘍学
老化に関する研究

背景:

年齢は癌の重要な危険因子です.
老化が腫瘍の制御に影響する正確なメカニズムは完全に理解されていません
癌の進行における免疫系老化の役割は,さらに明らかにする必要があります.

研究の目的:

免疫系の老化が肺がんの進行にどう影響するかを調べる
年齢に関係する癌の増殖を促す細胞と分子メカニズムを特定する
年齢に関係するがんのメカニズムを標的とした治療戦略を探求する.

主な方法:

血液形成の老化がマウスの肺腫瘍に及ぼす影響を研究した.
腫瘍の進行における骨髄細胞のような細胞とインタールイキン-1α (IL-1) の役割を分析した.
IL-1生成におけるDNAメチルトランスファーゼ3A (DNMT3A) の機能を調査した.
多種がんの腫瘍成長に対するIL- 1受容体1 (IL- 1R1) 信号伝達の障害の影響を評価した.
ヒトの腫瘍サンプルを年齢に関係する免疫細胞の浸透と予後的有意性について調べた.

主要な成果:

血液形成の老化は肺がんの進行を促します
IL- 1を産生する骨髄細胞のような細胞の蓄積は,免疫老化によって強化される.
年齢に関連したDNMT3Aの減少はIL-1の産生を増加させる.
IL- 1R1のシグナル伝達が早期に妨げられ,骨格形成が正常化し,肺,大腸,および臓の腫瘍の成長が抑制された.
人間の腫瘍は,高齢化,生存率の低下,再発に関連した,IL- 1を発現する単細胞由来マクロファージの濃縮を示した.

結論:

免疫系の老化は癌の進行の重要な要因です
IL-1/IL-1R1軸は,老化が腫瘍形成を促進する重要な経路を表しています.
IL-1R1のシグナル伝達をターゲットにすることで年齢に関係する癌の治療戦略が期待できるのです
年齢に伴う免疫変化を理解することで癌の治療や予防に役立つ洞察が得られます

さらに関連する動画

06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.4K

05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.1K

関連する概念動画

01:01

Regulation of Hematopoietic Stem Cells

3.2K

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

3.2K

01:21

Hematopoiesis

5.2K

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

5.2K

01:20

Overview of Hematopoiesis

3.9K

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

3.9K

01:19

Multipotency of Hematopoietic Stem Cells

3.0K

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

3.0K

01:28

Role of Hematopoietic Growth Factors

1.3K

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

1.3K

02:53

Adaptive Mechanisms in Cancer Cells

5.7K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...